News
Advent International has outbid KKR in a private equity bidding war for Spectris after the UK industrial group accepted its ...
Advent International said it increased its takeover bid for precision-measurement company Spectris to 4.2 billion pounds ($5.55 billion).
Precision instrument maker Spectris has agreed to be bought by Advent International after it trumped an offer from US ...
Advent’s increased offer represents a 2.5 percent increase to the KKR offer. This means the shareholders will receive an additional £1.00 per share, amounting to a total increase of £101.5 million ...
The firm is acting for the Just Group in its £2.4 billion sale, a month after it helped conclude the sale of Spectris to a ...
British scientific instruments maker Spectris SXS.L has agreed to private equity firm Advent's sweetened takeover offer worth ...
(Reuters) -British scientific instruments maker Spectris has agreed to private equity firm Advent's sweetened takeover bid valued at 4.8 billion pounds ($6.38 billion), including debt, the companies ...
Cognito Therapeutics today announced the presentation of new findings from a study of its non-invasive Spectris neuromodulation system.
4d
Clinical Trials Arena on MSNAAIC25: Cognito neuromodulation therapy slows decline in Alzheimer’s diseaseCognito’s OVERTURE trial demonstrated significant ‘time saved’ in functional and cognitive decline at both six and 18 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results